Powered by Gastroenterology & Hepatology APP Experts

The Digital Learning Hub for Gastroenterology & Hepatology APPs

Welcome to the GHAPP Digital Hub. GHAPP is committed to developing educational programs, advancing APP professional development, and curating resources for — and guided by — advanced practice providers in GI & liver care.

Faculty

Alison Moe

PA-C

Atlanta, GA, USA

Elizabeth Goacher

PA-C, MHS

Raleigh, NC

Ann Moore

NP

Phoenix, AZ

Christina Hanson

FNP-C

South Denver Gastroenterology

Gabriella McCarty

NP-C

North Shore Gastroenterology

Tedra Gray

NP-C

Sinai Medical Group

Kimberly Orleck

PA-C

Atlanta Gastroenterology Associates

Anne Feldman

NP

Cleveland Clinic Cleveland, OH

Corrie Berk

NP

The Texas Liver Institute

Lisa Richards

NP

UC San Diego

Jonathan Yeh

PA

Columbia University Irving Medical Center

Whitney Steinmetz

NP

Presbyterian Healthcare Services

Patrick Horne

NP

University of Florida

April Morris

FNP

Liver Institute of Virginia

Robin Soto

NP

UC San Diego Health

Podcasts

Podcast: Obesity and IMIDs: Unpacking the Epidemic and Its Far-Reaching Impacts

November 2025

GHAPPcast: Mental and Sexual Health Concerns & How To Address Them For Your IBD Patient

November 2025

GHAPPcast: IBS-C Therapies Explained: Helping Patients Understand Their Options

October 2025

GHAPPcast: Smarter Surveillance: The Rise of Algorithms like GALAD and Their Path to Practice

October 2025

GHAPPcast: Decoding Diagnostics: Why Biomarker Development Phases Are Your Clinical Ally

October 2025

GHAPPcast: Explaining IBS-C: Diagnosis and Communication That Builds Confidence

September 2025

Empowering PBC Patients: APPs’ Role in Education and Support

September 2025

GHAPPcast: Payer Tutorial

September 2025

Setting the Standard in Biomarker Validation: EDRN Example & Lessons from Liver Cancer

September 2025

Navigating Difficult Conversations: Discussing Prognosis and Lifelong Care in PBC

August 2025

Collaborating Across Specialties: How APPs Can Work with Hepatologists & Other Providers in PBC Care

August 2025

Managing PBC Symptoms in the Real World: Practical Tips for APPs

August 2025

GHAPPcast: Lifestyle and Nutrition Interventions for Constipation

July 2025

GHAPPcast: Mental Health Issues and Symptoms Related to IBS-C

July 2025

Setting Expectations When Initiating New Therapy

June 2025

Diagnosing IBS With Confidence

June 2025

Diagnosing EPI and Managing With The Appropriate PERT Dosing

June 2025

Implementing the IBS Guideline

May 2025

The Clinical Utility of Guselkumab in CD

March 2025

Simplifying Access: Prior Authorization Part 1

March 2025

Webcasts

Targeting the Drivers of IBD: GHAPP National 2025

October 2025

Navigating New Horizons: Evolutions of MASH Care

March 2025

Post Conference MASH Highlights from AASLD

February 2025

Post Conference MASH Highlights From ACG

February 2025

Post Conference MASH Highlights From EASL

February 2025

Post Conference MASH Highlights From DDW

February 2025

Hot Topics in Chronic Liver Disease and Gi Disorders

December 2025

Defining, Diagnosing, & Treating MASH

November 2024

Lifestyle Modifications for Patients With MASH

November 2025

Treatment of Metabolic Disorders and the Role of APPs in MASH

November 2025

Updates On Approved Treatments for MASH

November 2025

MASH Bootcamp Q&A

November 2025

Identifying & Diagnosing MASH Patients with Non-Invasive Tests

November 2025

2024 IBD Bootcamp

October 2024

PBC New Therapeutic

October 2024

FAQ Video Modules

FAQ: How Do You Explain Remission To A Patient?

November 2025

APP Insight: How Do You Develop a Treatment Plan for IBS-C? What Are Some Considerations?

November 2025

FAQ: What is the importance of biomarkers such as fecal calprotectin and CRP?

October 2025

FAQ: What Are the Next Steps When a Patient Still Has Active Disease When Taking Advanced Therapy?

October 2025

APP Insight: Conducting Meaningful Conversations to Assess Therapy Impact

October 2025

APP Insight: Evaluating Time to Response and Treatment Effectiveness

September 2025

APP Insight: Why Is It Important to Let Patients Know There Are Different Options for Treatment?

September 2025

What Is the Difference Between CIC and IBS-C?

July 2025

APP Insight: Discussing Exercise as a Complement to IBS-C Treatment

July 2025

FAQ: What Is the Significance of Alarm Symptoms Including Pathophysiology?

July 2025

APP Insight: Provide Diagnostic Tips for IBS-C

July 2025

Using the Bristol Stool Scale to Measure Response to Treatment

July 2025

FAQ: What Are the Main Causes of IBS, and How Does the Disease Progress Over Time?

July 2025

What Are the Most Critical Updates in Cirrhosis Research That Clinicians Should Be Aware Of?

March 2025

How Can Healthcare Professionals Improve Patient Outcomes in Those with Cirrhosis?

March 2025

Journal Club Video Modules

Week 48 Efficacy of Guselkumab vs. Ustekinumab in Crohn’s Disease: Insights from GALAXI 2 & 3

March 2025

Efficacy & Safety of Subcutaneous Guselkumab: 48-Week Results from the Phase 3 GRAVITI Study

March 2025

Efficacy and Safety of Guselkumab in Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results

February 2025

Guselkumab Efficacy & Safety in Moderate to Severe CD-GALAXI 2 & 3 Results

February 2025

Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study

January 2025

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis

January 2025

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

September 2024

Medication Review Video Modules

What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?

September 2024

What Is Resmetirom and How Does It Work to Treat MASH?

October 2024

Describe the Mechanism of Action of Guselkumab

December 2024

What Is Non-Responder Imputation and How Is It Utilized in Clinical Trials?

January 2025

How Is Guselkumab Dosed in IBD?

January 2025

What Is the Safety Profile of Guselkumab in Ulcerative Colitis and Crohn's Disease?

February 2025

What Is the Efficacy of Guselkumab in Ulcerative Colitis and Crohn's Disease?

February 2025

What Are Guselkumab's Other FDA Indications and How Might That Affect Patient Care?

February 2025

Publications

Associations of dietary indices with risk of all-cause and cardiovascular mortality in hypertensive adults

November 2025

Regulatory T cell stability determines the efficiency of bile duct regeneration during cholangitis

November 2025

Overlapping Esophageal Disorders: A Population-Based Comparative Study of Eosinophilic Esophagitis Patients Also Diagnosed With Achalasia

November 2025

Outcomes of endoscopic submucosal dissection for locally recurrent early gastric cancer after endoscopic resection: analysis of a multicenter prospective cohort study

November 2025

Identifying the Optimal Treatment for Patients with Hepatocellular Carcinoma and Clinically Significant Portal Hypertension: A Multicenter Propensity Score-Weighted Analysis

November 2025

Effect of Vonoprazan, potassium-competitive acid blocker, on Atezolizumab plus Bevacizumab efficacy in patients with hepatocellular carcinoma: a multicenter retrospective study

November 2025

Hepatitis E virus subtype 3f infections: rare but increasingly identified in Japan

November 2025

Normal organ [<sup>68</sup>Ga]DOTATOC uptake during PRRT: challenging the assumption of stable background shaped by cold somatostatin analogues treatment

November 2025

Multi-Mechanistic Persistence of Gastric Cancer Risk Post-Helicobacter pylori and Surveillance Strategies

November 2025

Methodological Considerations for Further Enhancing the Clinical Impact of the deTXlon Study

November 2025

Correspondence on "Risk of Gastric Adenocarcinoma After Eradication of Helicobacter pylori"

November 2025

Artificial Intelligence in Inflammatory Bowel Disease Management

November 2025

TXI Raises Detection of Non-Neoplastic Polyps Without Improving Clinically Meaningful Neoplasia Endpoints

November 2025

Enhancing Perioperative Documentation With Artificial Intelligence Scribes in Anesthesiology

November 2025

Obesity-Associated TRIM15 Promotes the Proliferation of Esophageal Adenocarcinoma Through the YY2/FOXRED1 Axis

November 2025

sectionimg

dotimg

Download the app and start using it now

Download on the App Store

GET IT ON Google Play